MCM2 and Carbonic Anhydrase 9 Are Novel Potential Targets for Neuroblastoma Pharmacological Treatment.

Garbati, Patrizia; Barbieri, Raffaella; Cangelosi, Davide; Zanon, Carlo; Costa, Delfina; Eva, Alessandra; Thellung, Stefano; Calderoni, Matilde; Baldini, Francesca; Tonini, Gian Paolo; Modesto, Paola; Florio, Tullio; Pagano, Aldo.

Afiliação

Garbati P; IRCCS Ospedale Policlinico San Martino, 16132 Genova, Italy.
Barbieri R; IRCCS Ospedale Policlinico San Martino, 16132 Genova, Italy.
Cangelosi D; Laboratory of Molecular Biology, IRCCS Giannina Gaslini Institute, 16147 Genova, Italy.
Zanon C; Istituto di Ricerca Pediatrica (IRP)-Fondazione Città della Speranza, Haematology-Oncology Lab, 35127 Padova, Italy.
Costa D; IRCCS Ospedale Policlinico San Martino, 16132 Genova, Italy.
Eva A; Laboratory of Molecular Biology, IRCCS Giannina Gaslini Institute, 16147 Genova, Italy.
Thellung S; Department of Internal Medicine and Centre of Excellence for Biomedical Research, University of Genova, 16132 Genova, Italy.
Calderoni M; Department of Experimental Medicine, University of Genova, 16132 Genova, Italy.
Baldini F; Department of Experimental Medicine, University of Genova, 16132 Genova, Italy.
Tonini GP; Istituto di Ricerca Pediatrica (IRP)-Fondazione Città della Speranza, Haematology-Oncology Lab, 35127 Padova, Italy.
Modesto P; National Reference Center for Veterinary and Comparative Oncology-Veterinary Medical Research Institute for Piemonte, Liguria and Valle d'Aosta, 10154 Torino, Italy.
Florio T; IRCCS Ospedale Policlinico San Martino, 16132 Genova, Italy.
Pagano A; Department of Internal Medicine and Centre of Excellence for Biomedical Research, University of Genova, 16132 Genova, Italy.